Viatris Certified as a Great Place to Work in India for the Third Consecutive Year

Feb 19, 2024

Telangana (Hyderabad) [India], February 19: Mylan Laboratories Limited (a Viatris Company) has been recognized with the prestigious Great Place to Work® CertificationTM in India...

Viatris Certified as a Great Place to Work in India for the Fourth Consecutive Year

Apr 02, 2025

Bangalore (Karnataka) [India], April 2: Mylan Laboratories Limited (a Viatris Company) has been recognized with the Great Place to Work® Certification™ in India for...

Biocon Biologics to acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in stock and cash

Mar 01, 2022

Bengaluru (Karnataka) [India], March 1 (ANI/PR Newswire): Biocon Biologics Ltd, a subsidiary of Biocon Ltd (BSE code: 532523) (NSE: BIOCON), has entered into a...

IQuest Enterprises acquires Viatris’ Indian API operations

Oct 02, 2023

Hyderabad (Telangana) [India], October 2: IQuest Enterprises has entered into a definitive agreement to acquire the API operations of global pharmaceutical major Viatris in...

Biocon Biologics completes acquisition of Viatris' Global Biosimilars Business

Nov 30, 2022

Bengaluru (Karnataka) [India], November 30 (ANI/PRNewswire): Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523) (NSE: BIOCON), announced today that it has...

Biocon subsidiary completes acquisition of Viatris for USD 3 billion

Nov 29, 2022

According to a statement by the pharma company, Biocon Biologics and Viatris have obtained all applicable approvals from key global regulators including the US...